number of access : ?
number of downloads : ?
ID 115283
Author
Bando, Hiroshi Tokushima University|Sakamoto Hospital KAKEN Search Researchers
Iwatsuki, Noboru Sakamoto Hospital
Sakamoto, Kazuki Sakamoto Hospital
Ogawa, Tomoya Sakamoto Hospital
Keywords
American diabetes association
estimated glomerular filtration rate
atherosclerotic cardiovascular disease
chronic kidney disease
diabetic kidney disease
Content Type
Journal Article
Description
Diabetes has been a prevalent disease worldwide, and metformin has been used widely as an oral hypoglycemic agent (OHA) for type 2 diabetes mellitus (T2DM). Its benefits include low cost, weight neutrality, general effect and positive efficacy for cardiovascular system. American Diabetes Association (ADA) has proposed diabetic guidelines-2020 and evaluated metformin as predominant agent. They include i) the preferred initial pharmacologic agent for T2DM, ii) once starting of metformin, it should be continued as long as tolerated without contraindication. Furthermore, recent studies showed safer effect for impaired renal function. We cannot exclude such results and will contribute the prevention of atherosclerotic cardiovascular disease (ASCVD).
Journal Title
Journal of Clinical Case Reports and Medical Research
Publisher
Ciencia Scientific Publisher
Volume
1
Issue
1
Start Page
JCCRMR-20-05
Published Date
2020-07-14
Rights
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license(https://creativecommons.org/licenses/by/4.0/)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences